| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |